The publication of a peer-reviewed article often lends credibility to medical technologies, which can lead to increased adoption by practitioners and demand by patients. As Renuvion is a proprietary technology of Apyx Medical, positive study results are likely to have a direct impact on the company's product sales and, consequently, its stock price in the short term.